Catalyst Wire Dossier Catalyst Wire Dossier

Crecheck Tablet 2.5 mg

Rosuvastatin calcium · Hanlim Pharm. Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Crecheck Tablet 2.5 mg, covering 2024-06-27 to 2024-06-27. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate the Bioequivalence of "Crecheck Tablet 2.5 mg (Rosuvastatin Calcium)" and "Crestor Tablet 5 mg (Rosuvastatin Calcium)" in Healthy Adult Subjects [Phase 1]

See pricing